Setting the Stage for R&D

The WHO has drawn up its 2018 R&D Blueprint, highlighting priority diseases with the greatest epidemic potential that lack sufficient countermeasures.

The second annual review's 8 diseases include an as-yet-unknown Disease X, Crimean-Congo hemorrhagic fever, Ebola and Marburg viruses, Lassa fever, MERS-CoV, SARS, Zika, Nipah and henipaviral diseases, Rift Valley fever.

Though not flagged as a priority, the need for better diagnostics for diseases like monkeypox and leptospirosis were part of the conversation.

The reviewers acknowledged the public health risk of diseases including HIV/AIDs, tuberculosis and malaria, but considered them beyond the Blueprint’s scope.


Comments +


Post a Comment

Restricted HTML

  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Back to top